Exelixis | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Amgen USD 694M 29M 2025-06
AstraZeneca 303M 126M 2025-06
Bayer 495M 89M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Cytokinetics USD 24.26M 1.32M 2025-06
Eisai 916M 174M 2025-06
Eli Lilly USD 249M 5.3M 2025-06
Exelixis 23.4M 3.9M 2023-09
Genmab DKK 9M 4M 2025-06
Glaxosmithkline 178.05M 24.73M 2024-12
Incyte USD 594K 66K 2025-06
Ionis Pharmaceuticals USD 19M 0 2025-06
MacroGenics USD -24000 24K 2024-12
Merck USD 305M 8M 2025-06
Moderna USD 1000K 0 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 289M 19M 2025-06
Pfizer USD 654M 0 2025-06
Sanofi 66.11M 20.67M 2024-12
Takeda 107.16B 56.83B 2025-06
Ultragenyx Pharmaceutical 14.04M 1.48M 2025-06
Xencor 8.24M 422K 2025-06


Exelixis Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.